Kessel D, Ratanatharathorn V, Chou T H
Cancer Res. 1979 Sep;39(9):3377-80.
Electrofocusing patterns of plasma fucosyltransferases provide information concerning marrow status of patients with myeloproliferative disorders. Three enzymes were detected in normal plasmas using an acceptor terminating in the sequence N-acetylglucosamine-galactose. The enzyme which focused at pH 4.7 was elevated during rapid proliferation of myeloid cells, e.g., acute myelogenous leukemias and certain infectious diseases. Activity at pI = 5.1 was decreased in acute myelogenous leukemia patients, and from other observations, appears related to the level of erythropoietic activity. Acceptor studies show this enzyme to be specified by the H gene. A third enzyme focused at pH 5.5 and appeared to be correlated with a later step in granulocytes maturation. Two other plasma fucosyltransferases (pl = 5.6 and 8.3) were detected with a high-molecular-weight acceptor terminating in N-acetylglucosamine. This activity was markedly elevated during regeneration of a normal marrow population during drug-induced remission of acute myelogenous leukemia. Additional isoenzymes were detected, using this acceptor, in plasma of patients with certain solid tumors and multiple myeloma. However, the new isoelectric points observed (pH 6.0, 6.9, and 7.8) suggest these enzymes are probably not derived from hematopoietic tissues.
血浆岩藻糖基转移酶的电聚焦图谱为骨髓增殖性疾病患者的骨髓状态提供了相关信息。使用以N - 乙酰葡糖胺 - 半乳糖序列结尾的受体,在正常血浆中检测到三种酶。聚焦于pH 4.7的酶在髓样细胞快速增殖期间升高,例如急性髓性白血病和某些传染病。急性髓性白血病患者中pI = 5.1时的活性降低,从其他观察结果来看,似乎与红细胞生成活性水平有关。受体研究表明这种酶由H基因指定。第三种酶聚焦于pH 5.5,似乎与粒细胞成熟的后期步骤相关。用一种以N - 乙酰葡糖胺结尾的高分子量受体检测到另外两种血浆岩藻糖基转移酶(pI = 5.6和8.3)。在急性髓性白血病药物诱导缓解期间正常骨髓群体再生过程中,这种活性显著升高。使用这种受体,在某些实体瘤和多发性骨髓瘤患者的血浆中检测到了额外的同工酶。然而,观察到的新等电点(pH 6.0、6.9和7.8)表明这些酶可能并非来自造血组织。